understanding pharmacokinetic parameters describing nanomaterial disposition body greatly facilitate development firm foundation risk assessment based review focuses disposition carbon based fullerenes nanotubes quantum dots qd parenteral administration rodents common theme particle types major determinant nanomaterial disposition degree interaction reticuloendothelial cell system water soluble particles evading system excreted kidney larger particles proper surface charge targeted cells liver spleen organs nanomaterial kinetics characterized short blood half lives reflecting tissue extraction clearance body common attribute nanomaterial kinetics retention particles body finally organic drugs nanomaterials preferentially trafficked body lymphatic system obvious immunological implications 